首页> 美国卫生研究院文献>Cancer Management and Research >The role of digital breast tomosynthesis in breast cancer screening: a manufacturer- and metrics-specific analysis
【2h】

The role of digital breast tomosynthesis in breast cancer screening: a manufacturer- and metrics-specific analysis

机译:数字化乳房断层合成在乳腺癌筛查中的作用:针对制造商和指标的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Digital Breast Tomosynthesis (DBT), with or without Digital Mammography (DM) or Synthetic Mammography (SM), has been introduced or is under consideration for its introduction in breast cancer screening in several countries, as it has been shown that it has advantages over DM. Despite this there is no agreement on how to implement DBT in screening, and in many cases there is a lack of official guidance on the optimum usage of each commercially available system. The aim of this review is to carry out a manufacturer-specific summary of studies on the implementation of DBT in breast cancer screening.
机译:在一些国家,已引入或正在考虑将数字乳腺断层合成术(DBT)(带有或不带有数字乳房X线摄影术(DM)或合成乳房X线摄影术(SM))引入或正在考虑将其引入乳腺癌筛查中。 DM。尽管如此,在筛查中如何实施DBT尚无共识,而且在许多情况下,对于每种市售系统的最佳使用都缺乏官方指导。这篇综述的目的是针对乳腺癌筛查中DBT的实施进行针对制造商的研究总结。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号